What Is BPC-157? Research Peptide Overview

If you've searched "what is BPC-157," you've probably seen it described as a recovery or healing peptide. In the laboratory context it's more precise to call it a synthetic, gastric-derived peptide that's studied in tissue-repair and angiogenesis models. This overview covers its origin, its mechanism as understood from published research, and what it's investigated for — strictly as a research reference standard for in-vitro and animal study. Explore the BPC-157 research kit for specifications.

What is BPC-157?

BPC-157 (Body Protection Compound 157) is a synthetic peptide of 15 amino acids. Its sequence is derived from a larger protein found in human gastric juice — the digestive fluid of the stomach. Because the parent protein is associated with the protective and regenerative properties of the gastric lining, the synthesized fragment has become a frequent subject of tissue-repair research. It is supplied lyophilized (freeze-dried) for reconstitution in the lab.

Where does its sequence come from?

BPC-157 is described in the literature as a "stable gastric pentadecapeptide." The term reflects two things: it's a 15-residue (pentadeca) peptide, and the source sequence comes from gastric tissue. The parent compound, BPC (Body Protection Compound), was isolated from gastric juice, and the 157 fragment captures the region most associated with that protein's protective profile in early research. Synthesizing the fragment directly — rather than extracting the whole protein — gives researchers a defined, reproducible molecule to work with.

A notable practical feature is stability. Unlike many peptides that degrade quickly in aqueous or acidic conditions, BPC-157 holds up well in published in-vitro work, including in simulated gastric environments. That robustness is part of why it became such a widely used research model: a stable compound is easier to handle, store, and study across assays without confounding degradation effects.

What is BPC-157 studied for?

Research on BPC-157 clusters around a few mechanistic themes. The most-cited is angiogenesis — the formation of new blood vessels — which appears in studies as a driver of tissue repair. Around that core, the literature branches into structural-repair and gastrointestinal models. The BPC-157 reference standard is used across all of these to examine the relevant pathways.

Angiogenesis models

A recurring theme in the literature is BPC-157's association with the VEGFR2 (vascular endothelial growth factor receptor 2) signaling pathway and the nitric-oxide system in angiogenesis assays. New blood-vessel formation is a prerequisite for tissue remodeling — repaired tissue needs a blood supply — which is what links these vascular models to the broader repair literature. Endothelial-cell tube-formation and migration assays are common readouts.

Tendon, ligament, and muscle repair models

Animal-model studies have examined BPC-157 in the context of tendon-to-bone healing, ligament injury, and muscle repair, often measuring fibroblast migration, collagen organization, and the recovery of mechanical strength in the repaired tissue. These are the models that gave BPC-157 its reputation as a "recovery" research peptide, and they remain the most-referenced application in the niche. Researchers in these models typically track outgrowth of tendon fibroblasts and the density of newly formed collagen.

Gastrointestinal protection models

Given its gastric origin, BPC-157 is also studied in GI-protection models — examining the integrity of the gut lining under various experimental stressors, the maintenance of mucosal blood flow, and markers of intestinal-barrier function. This GI work ties back to where the compound's sequence came from, closing the loop between its origin and one of its most-studied model systems.

Why BPC-157 became a popular research model

Several factors compound to make BPC-157 the anchor of the recovery cluster. Its stability simplifies handling. Its mechanism touches angiogenesis, a pathway central to almost all tissue repair, giving it broad relevance across model systems. And its long publication history means new studies have abundant prior work to build on. For a researcher choosing a first tissue-repair compound, that depth of documentation is the practical argument — there's simply more characterized methodology to draw from than for newer compounds.

How is BPC-157 supplied for research?

Eon Research supplies BPC-157 lyophilized in multi-vial research kits from our US facility with tracking. The freeze-dried powder is stable for transport and storage, and is reconstituted with bacteriostatic water before use — the reconstitution calculator computes concentration and aliquot volumes for any vial size. Order the BPC-157 research kit to get started.

Lyophilized BPC-157 is generally held cold and out of light until reconstitution; once in solution, bacteriostatic water's benzyl alcohol extends the usable window for multi-session research.

BPC-157 and TB-500

BPC-157 is frequently studied alongside TB-500, a Thymosin Beta-4 fragment, because their mechanisms are complementary — local repair versus systemic cell migration. Read what TB-500 is for the companion model. The two are available together as the BPC-157 + TB-500 blend kit; see our BPC-157 vs TB-500 comparison for the distinction.